Comparisons between intestinal and diffuse gastric cancer in response to apatinib: Data from post-marketing phase IV study.-MedSci.cn

Comparisons between intestinal and diffuse gastric cancer in response to apatinib: Data from post-marketing phase IV study.

Zhang, GF; Qin, SK; Li, J; Deng, WY; Wen, L; Wang, JS; Zhong, HJ; Jia, TF; Yang, JW; Ba, Y; Lin, XY; Wang, M; Wang, L; Liu, LK; He, YF; Tao, M; Xie, CY; Ye, F; Wu, XY; Bai, YX

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (4):

科室
- - 订阅+
  - 更多科室
工具
服务

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Comparisons between intestinal and diffuse gastric cancer in response to apatinib: Data from post-marketing phase IV study.

科室

工具

服务